Poseida Therapeutics, Inc. earnings per share and revenue

PSTX earnings per share for the last quarter are -0.25 USD whereas the estimation was -0.42 USD which accounts for 40.48% surprise. Company revenue for the same period amounts to 28.14 M USD despite the estimated figure of 11.67 M USD. Estimated earnings per share for the next quarter are -0.41 USD, and revenue is expected to reach 15.42 M USD. Also watch annual changes over time to get a bigger picture of PSTX earnings per share and revenue dynamics.